TY  - GEN
AU  - Jabbour,E
AU  - Deininger,M
AU  - Hochhaus,A
TI  - Management of adverse events associated with tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia
SN  - 1476-5551
PY  - 2011///0408
KW  - Benzamides
KW  - Dasatinib
KW  - Disease Management
KW  - Humans
KW  - Imatinib Mesylate
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - complications
KW  - Piperazines
KW  - adverse effects
KW  - Protein Kinase Inhibitors
KW  - Protein-Tyrosine Kinases
KW  - antagonists & inhibitors
KW  - Pyrimidines
KW  - Thiazoles
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
UR  - https://doi.org/10.1038/leu.2010.215
ER  -